Inventor · disambiguated record
Wolfgang Fraunhofer
Also filed as: FRAUNHOFER WOLFGANG
13 granted patents·17 pending applications·700 citations·filing 2007–2022
94Inventor score
Files withABBVIE BIOTECHNOLOGY LTD15ABBVIE INC5BORHANI DAVID W3FRAUNHOFER WOLFGANG3ABBOTT BIOTECH LTD2
Top patents by PatentIndex Score
30 records- 0198US8034906B2Crystalline anti-hTNFalpha antibodiesABBOTT BIOTECH LTD·Filed 2007·Granted Oct 11, 2011·105 cites·26 claims
- 0297US9085619B2Anti-TNF antibody formulationsABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 21, 2015·83 cites·30 claims
- 0396US8883146B2Protein formulations and methods of making sameABBVIE INC·Filed 2013·Granted Nov 11, 2014·102 cites·18 claims
- 0496US8436149B2Crystalline anti-hTNFalpha antibodiesBORHANI DAVID W·Filed 2011·Granted May 7, 2013·87 cites·27 claims
- 0595US8420081B2Antibody formulations and methods of making sameFRAUNHOFER WOLFGANG·Filed 2008·Granted Apr 16, 2013·165 cites·135 claims
- 0692US8168760B2Crystalline anti-human IL-12 antibodiesBORHANI DAVID W·Filed 2008·Granted May 1, 2012·22 cites·45 claims
- 0791US8821865B2High concentration anti-TNFα antibody liquid formulationsNEU MICHAEL·Filed 2011·Granted Sep 2, 2014·116 cites·11 claims
- 0889US8753839B2Compositions and methods for crystallizing antibodiesFRAUNHOFER WOLFGANG·Filed 2008·Granted Jun 17, 2014·16 cites·57 claims
- 0978US8404819B2Crystalline anti-human IL-12 antibodiesBORHANI DAVID W·Filed 2012·Granted Mar 26, 2013·3 cites·49 claims
- 1075US11191834B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Dec 7, 2021·0 cites·20 claims
- 1175US11167030B2Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2020·Granted Nov 9, 2021·0 cites·20 claims
- 1273US2019358322A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 1372US8772458B2Crystalline anti-hTNFalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Jul 8, 2014·1 cites·21 claims
- 1469US2022010005A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 1567US2017143828A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2017·Application pending·0 cites
- 1663US2015361170A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 1761US2015183863A1Crystalline anti-htnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1861US2016222101A1Protein formulations and methods of making sameABBVIE INC·Filed 2016·Application pending·0 cites
- 1960US8940873B2Crystalline anti-human IL-12 antibodiesABBVIE INC·Filed 2013·Granted Jan 27, 2015·0 cites·19 claims
- 2059US2010172862A1Stable antibody compositions and methods of stabilizing sameABBOTT LAB·Filed 2009·Application pending·0 cites
- 2159US2019211093A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 2259US2014377275A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONSABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2358US2023007847A1Protein formulations and methods of making sameABBVIE BIOTECHNOLOGY LTD·Filed 2022·Application pending·0 cites
- 2454US2014141007A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2554US2014141008A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2653US2015166648A1Compositions and Methods for Crystallizing AntibodiesABBVIE INC·Filed 2014·Application pending·0 cites
- 2752US2015071944A1Stable antibody compositions and methods of stabilizing sameABBVIE INC·Filed 2014·Application pending·0 cites
- 2850US2016017030A1HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATIONABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2945US2010278822A1Stable high protein concentration formulations of human anti-tnf-alpha-antibodiesABBOTT BIOTECH LTD·Filed 2010·Application pending·0 cites
- 3034US2011256135A1Anti-nerve growth factor (ngf) antibody compositionsFRAUNHOFER WOLFGANG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wolfgang Fraunhofer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →